Publication | Closed Access

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Hematological MalignancyOncologyLeast SixBone Marrow FailureBlood TransfusionTransfusion MedicineTransfusion-dependent PatientsHematologyMedicineAplastic Anemia